SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000006
Filing Date
2021-01-11
Accepted
2021-01-11 16:37:38
Documents
15
Period of Report
2021-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20210111.htm   iXBRL 8-K 52309
2 EX-99.1 ex991-goldenberry.htm EX-99.1 27126
  Complete submission text file 0001651308-21-000006.txt   239477

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210111.xsd EX-101.SCH 2505
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20210111_cal.xml EX-101.CAL 793
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20210111_def.xml EX-101.DEF 1757
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210111_lab.xml EX-101.LAB 25214
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210111_pre.xml EX-101.PRE 13249
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210111_htm.xml XML 11810
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 21521225
SIC: 2834 Pharmaceutical Preparations